{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:13:43Z","timestamp":1790972023571,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jss.2022.09.011","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T19:28:55Z","timestamp":1666207735000},"page":"118-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Inhibition of Glypican-3 Cleavage Results in Reduced Cell Proliferation in a Liver Cancer Cell Line"],"prefix":"10.1016","volume":"282","author":[{"given":"Emily J.","family":"Schepers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charissa","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Bondoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2022.09.011_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/children6010001","article-title":"Hepatoblastoma\u2014the evolution of biology, surgery, and transplantation","volume":"6","author":"Lim","year":"2019","journal-title":"Children"},{"key":"10.1016\/j.jss.2022.09.011_bib2","doi-asserted-by":"crossref","first-page":"pkz007","DOI":"10.1093\/jncics\/pkz007","article-title":"Trends in international incidence of pediatric cancers in children under 5 years of age: 1988-2012","volume":"3","author":"Hubbard","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.jss.2022.09.011_bib3","first-page":"3380","article-title":"LRP1 mediates Hedgehog-induced endocytosis of the GPC3\u2013Hedgehog complex","volume":"125","author":"Capurro","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jss.2022.09.011_bib4","series-title":"Heterogeneity of Hepatic Cancer Stem Cells. Stem Cells Heterogeneity in Cancer","first-page":"59","author":"Sukowati","year":"2019"},{"key":"10.1016\/j.jss.2022.09.011_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jss.2022.09.011_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/cancers12020273","article-title":"Animal modeling of pediatric liver cancer","volume":"12","author":"Whitlock","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jss.2022.09.011_bib7","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","article-title":"Hep G2 is a hepatoblastoma-derived cell line","volume":"40","author":"L\u00f3pez-Terrada","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jss.2022.09.011_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fonc.2019.00108","article-title":"Immunotherapeutic targeting of GPC3 in pediatric solid embryonal tumors","volume":"9","author":"Ortiz","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jss.2022.09.011_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.humpath.2007.06.006","article-title":"Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases","volume":"39","author":"Zynger","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jss.2022.09.011_bib10","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/hep.30646","article-title":"A frizzled-like cysteine-rich domain in glypican-3 mediates wnt binding and regulates hepatocellular carcinoma tumor growth in mice","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jss.2022.09.011_bib11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1309\/HCQWPWD50XHD2DW6","article-title":"Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples","volume":"129","author":"Baumhoer","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jss.2022.09.011_bib12","first-page":"1333","article-title":"Expression pattern of glypican-3-GPC3-during human embryonic and fetal development","volume":"23","author":"Iglesias","year":"2008","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.jss.2022.09.011_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2008-9-5-224","article-title":"Glypicans","volume":"9","author":"Filmus","year":"2008","journal-title":"Genome Biol"},{"key":"10.1016\/j.jss.2022.09.011_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3389\/fonc.2019.00708","article-title":"The role of glypican-3 in regulating wnt, YAP and hedgehog in liver cancer","volume":"9","author":"Kolluri","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jss.2022.09.011_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejca.2010.10.024","article-title":"Glypican-3: a new target for cancer immunotherapy","volume":"47","author":"Ho","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2022.09.011_bib16","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192466","article-title":"Wnt\/\u03b2-catenin signaling as a useful therapeutic target in hepatoblastoma","volume":"39","author":"Sha","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jss.2022.09.011_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/105221616X693639","article-title":"Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt\/\u03b2-catenin perspective","volume":"17","author":"Bell","year":"2017","journal-title":"Gene Expr"},{"key":"10.1016\/j.jss.2022.09.011_bib18","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1158\/0008-5472.CAN-03-2191","article-title":"Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma","volume":"64","author":"Hippo","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2022.09.011_bib19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hep.21328","article-title":"Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas","volume":"44","author":"Luo","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jss.2022.09.011_bib20","doi-asserted-by":"crossref","first-page":"148651","DOI":"10.1155\/2015\/148651","article-title":"Liver-specific inactivation of the proprotein convertase FURIN leads to increased hepatocellular carcinoma growth","volume":"2015","author":"Declercq","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jss.2022.09.011_bib21","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1074\/jbc.M114.612705","article-title":"Processing by convertases is required for glypican-3-induced inhibition of Hedgehog signaling","volume":"290","author":"Capurro","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2022.09.011_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/1098-2744(200006)28:2<63::AID-MC1>3.0.CO;2-C","article-title":"The proprotein convertases furin and PACE4 play a significant role in tumor progression","volume":"28","author":"Bassi","year":"2000","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jss.2022.09.011_bib23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/ijms12021060","article-title":"FurinDB: a database of 20-residue furin cleavage site motifs, substrates and their associated drugs","volume":"12","author":"Tian","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jss.2022.09.011_bib24","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41388-021-02175-9","article-title":"The proprotein convertase furin in cancer: more than an oncogene","volume":"41","author":"He","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jss.2022.09.011_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-43093-x","article-title":"Influence of SHH\/GLI1 axis on EMT mediated migration and invasion of breast cancer cells","volume":"9","author":"Riaz","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jss.2022.09.011_bib26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.devcel.2008.03.006","article-title":"Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding","volume":"14","author":"Capurro","year":"2008","journal-title":"Dev Cell"},{"key":"10.1016\/j.jss.2022.09.011_bib27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.26996","article-title":"Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy","volume":"60","author":"Gao","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jss.2022.09.011_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.trecan.2018.09.004","article-title":"Glypicans as cancer therapeutic targets","volume":"4","author":"Li","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jss.2022.09.011_bib29","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1021\/acs.biochem.7b01208","article-title":"Role of glycanation and convertase maturation of soluble glypican-3 in inhibiting proliferation of hepatocellular carcinoma cells","volume":"57","author":"Saad","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.jss.2022.09.011_bib30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/med.21455","article-title":"Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment","volume":"38","author":"Zhou","year":"2017","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jss.2022.09.011_bib31","doi-asserted-by":"crossref","first-page":"45932","DOI":"10.1038\/srep45932","article-title":"Glypican 3 as a serum marker for hepatoblastoma","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jss.2022.09.011_bib32","first-page":"5179","article-title":"Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution","volume":"57","author":"Hsu","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2022.09.011_bib33","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1158\/0008-5472.CAN-04-4244","article-title":"Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling","volume":"65","author":"Capurro","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2022.09.011_bib34","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1007\/s00432-018-2751-0","article-title":"Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway","volume":"144","author":"Fern\u00e1ndez","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jss.2022.09.011_bib35","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.7150\/jca.39972","article-title":"Glypican-3: a new target for diagnosis and treatment of hepatocellular carcinoma","volume":"11","author":"Guo","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.jss.2022.09.011_bib36","doi-asserted-by":"crossref","first-page":"60133","DOI":"10.18632\/oncotarget.11107","article-title":"Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells","volume":"7","author":"Castillo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2022.09.011_bib37","doi-asserted-by":"crossref","first-page":"44406","DOI":"10.18632\/oncotarget.9763","article-title":"Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer","volume":"7","author":"Han","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2022.09.011_bib38","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.bcp.2006.02.006","article-title":"Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells","volume":"71","author":"H\u00f6pfner","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jss.2022.09.011_bib39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2015.08.004","article-title":"Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells","volume":"368","author":"Hsiao","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jss.2022.09.011_bib40","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3892\/mmr.2013.1279","article-title":"Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis","volume":"7","author":"Pan","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jss.2022.09.011_bib41","first-page":"970","article-title":"Elevated GPC3 level promotes cell proliferation in liver cancer","volume":"16","author":"Wang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jss.2022.09.011_bib42","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3892\/ijo.2017.3896","article-title":"Furin promotes epithelial-mesenchymal transition in pancreatic cancer cells via Hippo-YAP pathway","volume":"50","author":"Zhang","year":"2017","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jss.2022.09.011_bib43","doi-asserted-by":"crossref","first-page":"36788","DOI":"10.1074\/jbc.M400484200","article-title":"Inhibition of Furin\u00a0by Polyarginine-Containing Peptides","volume":"279","author":"Kacprzak","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2022.09.011_bib44","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10529-016-2064-9","article-title":"Improved delivery of Cas9 protein\/gRNA complexes using lipofectamine CRISPRMAX","volume":"38","author":"Yu","year":"2016","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.jss.2022.09.011_bib45","doi-asserted-by":"crossref","first-page":"20180709","DOI":"10.1098\/rsif.2018.0709","article-title":"In\u00a0vitro cell migration quantification method for scratch assays","volume":"16","author":"Bobadilla","year":"2019","journal-title":"J R Soc Interf"},{"key":"10.1016\/j.jss.2022.09.011_bib46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s42003-021-02562-8","article-title":"Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma","volume":"4","author":"Bondoc","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.jss.2022.09.011_bib47","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ymthe.2017.12.012","article-title":"Development of GPC3-specific chimeric antigen receptor-engineered natural killer cells for the treatment of hepatocellular carcinoma","volume":"26","author":"Yu","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.jss.2022.09.011_bib48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/11595360-000000000-00000","article-title":"Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin","volume":"25","author":"Ho","year":"2011","journal-title":"BioDrugs"},{"key":"10.1016\/j.jss.2022.09.011_bib49","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.18103\/mra.v8i6.2163","article-title":"Novel therapeutics in hepatoblastoma","volume":"8","author":"Wadhwani","year":"2020","journal-title":"Med Res Arch"},{"key":"10.1016\/j.jss.2022.09.011_bib50","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fimmu.2016.00690","article-title":"Anti-GPC3-CAR T cells suppress the growth of tumor cells in patient-derived xenografts of hepatocellular carcinoma","volume":"7","author":"Jiang","year":"2017","journal-title":"Front Immunol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480422005923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480422005923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:00:27Z","timestamp":1758380427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480422005923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":50,"alternative-id":["S0022480422005923"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2022.09.011","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Glypican-3 Cleavage Results in Reduced Cell Proliferation in a Liver Cancer Cell Line","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2022.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}